Matrix Latest Drug Testing News | Matrix Diagnostics
Trends and challenges of an evolving cannabis landscape
18 October 2024
Posted By Matrix Diagnostics
0 Comments
In November 2018, the UK government legalised the prescription of medicinal cannabis by specialist doctors. To date, recreational (or non-medical) cannabis has not been legalised. This means that under the Misuse of Drugs Act 1971, persons producing, distributing or using unprescribed cannabis can be arrested and prosecuted. The legalisation of cannabis Globally, the use of
How workplace drug testing helps to save money in the war on drugs
24 September 2024
Posted By Matrix Diagnostics
0 Comments
Recently, there has been a lot of focus on funding to combat drug misuse and drug trafficking. At the end of 2021, the UK government announced a 10-year plan to actively tackle drug supply chains while capping the demand for drugs through treatment programmes. Allocated funding and initiatives A total of £3bn was earmarked for
Government bans xylazine and other substances to curb drug deaths
18 September 2024
Posted By Matrix Diagnostics
0 Comments
The UK Government has initiated steps to ban xylazine and 21 other drugs. After an investigation, the Advisory Council on the Misuse of Drugs (ACMD) recommended this ban as part of the continued battle against drug trafficking and alarmingly high drug deaths. Xylazine is a veterinary sedative and drug dealers often combine it with opioids
Matrix Diagnostics Achieves UKAS Accreditation for Oral Fluid Toxicology Analysis
2 September 2024
Posted By Oliwia Zakrzewska
0 Comments
We are pleased to announce that on 22nd August 2024, Matrix Diagnostics was awarded UKAS accreditation for analysis of oral fluid toxicology samples using a solid phase extraction method. This is a significant development for the Laboratory Team and is the culmination of a project to improve our technical methods for oral fluid analysis. The
